MARKET

CRMD

CRMD

Cormedix
NASDAQ
7.69
+0.34
+4.63%
After Hours: 7.66 -0.03 -0.38% 19:59 02/06 EST
OPEN
7.48
PREV CLOSE
7.35
HIGH
7.72
LOW
7.40
VOLUME
1.57M
TURNOVER
--
52 WEEK HIGH
17.43
52 WEEK LOW
5.60
MARKET CAP
605.89M
P/E (TTM)
3.746
1D
5D
1M
3M
1Y
5Y
1D
Catalyst Watch: Crypto swings, FedEx investor event, and Super Bowl bets
Seeking Alpha · 15h ago
Analysts’ Top Healthcare Picks: Cormedix (CRMD), CG Oncology, Inc. (CGON)
TipRanks · 2d ago
CorMedix Shares Rise After $75M Buyback Authorization
Dow Jones · 4d ago
CorMedix sets $75M stock buyback plan
Seeking Alpha · 4d ago
CorMedix Announces $75 Mln Share Buyback Program
NASDAQ · 4d ago
CorMedix Therapeutics Announces $75M Buyback Plan
Benzinga · 4d ago
CorMedix board authorizes share repurchase program of up to $75M
TipRanks · 4d ago
*CorMedix Therapeutics Announces Share-Repurchase Program of Up to $75M
Dow Jones · 4d ago
More
About CRMD
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.

Webull offers CorMedix Inc stock information, including NASDAQ: CRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRMD stock methods without spending real money on the virtual paper trading platform.